318 related articles for article (PubMed ID: 18991035)
1. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.
Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N
Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937
[TBL] [Abstract][Full Text] [Related]
3. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial.
Keklikci U; Dursun B; Cingu AK
Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E
Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058
[TBL] [Abstract][Full Text] [Related]
5. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study.
Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D;
Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775
[TBL] [Abstract][Full Text] [Related]
6. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
[TBL] [Abstract][Full Text] [Related]
8. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
Ozcan AA; Ersoz TR; Dulger E
Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
Yücel OE; Ulus ND
Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
[TBL] [Abstract][Full Text] [Related]
10. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients].
Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L
Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374
[TBL] [Abstract][Full Text] [Related]
11. Role of ocular cytology in vernal keratoconjunctivitis.
Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood.
Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L
Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629
[TBL] [Abstract][Full Text] [Related]
13. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial.
De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P
Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151
[TBL] [Abstract][Full Text] [Related]
14. Vernal keratoconjunctivitis in Thailand.
Kosrirukvongs P; Vichyanond P; Wongsawad W
Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical 0.05% cyclosporine treatment in children with severe vernal keratoconjunctivitis.
Çoban-Karataş M; Özkale Y; Altan-Yaycıoğlu R; Sızmaz S; Pelit A; Metindoğan S; Cantürk-Uğurbaş S; Aydın-Akova Y
Turk J Pediatr; 2014; 56(4):410-7. PubMed ID: 25818961
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
Wan Q; Tang J; Han Y; Wang D; Ye H
Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
[TBL] [Abstract][Full Text] [Related]
18. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
[TBL] [Abstract][Full Text] [Related]
20. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
Oray M; Toker E
Cornea; 2013 Aug; 32(8):1149-54. PubMed ID: 23676782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
